Efficacy of Single Dose of a Bivalent Vaccine Containing Inactivated Newcastle Disease Virus and Reassortant Highly Pathogenic Avian Influenza H5N1 Virus against Lethal HPAI and NDV Infection in Chickens |
| |
Authors: | Dong-Hun Lee Jae-Keun Park Jung-Hoon Kwon Seong-Su Yuk Tseren-Ochir Erdene-Ochir Yo-Han Jang Baik-Lin Seong Joong-Bok Lee Seung-Yong Park In-Soo Choi Chang-Seon Song |
| |
Affiliation: | 1. Avian Disease Laboratory, College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea.; 2. Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.; The University of Hong Kong, Hong Kong, |
| |
Abstract: | Highly pathogenic avian influenza (HPAI) and Newcastle disease (ND) are 2 devastating diseases of poultry, which cause great economic losses to the poultry industry. In the present study, we developed a bivalent vaccine containing antigens of inactivated ND and reassortant HPAI H5N1 viruses as a candidate poultry vaccine, and we evaluated its immunogenicity and protective efficacy in specific pathogen-free chickens. The 6∶2 reassortant H5N1 vaccine strain containing the surface genes of the A/Chicken/Korea/ES/2003(H5N1) virus was successfully generated by reverse genetics. A polybasic cleavage site of the hemagglutinin segment was replaced by a monobasic cleavage site. We characterized the reverse genetics-derived reassortant HPAI H5N1 clade 2.5 vaccine strain by evaluating its growth kinetics in eggs, minimum effective dose in chickens, and cross-clade immunogenicity against HPAI clade 1 and 2. The bivalent vaccine was prepared by emulsifying inactivated ND (La Sota strain) and reassortant HPAI viruses with Montanide ISA 70 adjuvant. A single immunization with this vaccine induced high levels of hemagglutination-inhibiting antibody titers and protected chickens against a lethal challenge with the wild-type HPAI and ND viruses. Our results demonstrate that the bivalent, inactivated vaccine developed in this study is a promising approach for the control of both HPAI H5N1 and ND viral infections. |
| |
Keywords: | |
|
|